Disease activity trajectories in juvenile dermatomyositis from childhood to adulthood

Tomo Nozawa,Eleanor M Pullenayegum,Audrey Bell-Peter,Jo-Anne Marcuz,Kristi Whitney,Ophir Vinik,Rachel Shupak,Saunya Dover,Brian M Feldman

DOI: https://doi.org/10.1093/rheumatology/keae027

2024-01-12

Rheumatology

Abstract:Abstract Objectives To assess whether there are identifiable subgroups of disease activity trajectory in a population of JDM patients—followed throughout childhood and into adulthood—and determine factors that predict those trajectory groupings. Methods This is a retrospective, longitudinal inception cohort of patients with idiopathic inflammatory myopathies, largely JDM. We sought to identify baseline factors that predict membership into different groups (latent classes) of disease activity trajectory. Results A total of 172 patients (64% females), with median age at diagnosis of 7.7 years, were analysed. We studied 4725 visits (1471 patient-years). We identified three latent classes of longitudinal disease activity, as measured by the modified DAS (DASm), with distinct class trajectories predicted by DASm at baseline, and by the changes of DASm from either baseline to 3 months or baseline to 6 months (early response to therapy). In the analysis in which DASm at baseline and the changes of DASm from baseline to 6 months are included as predictors, Class 1 (10%) has persistently high disease activity, Class 2 (34%) is characterized by moderate disease activity and Class 3 (56%) is characterized by individuals with a high early disease activity but an apparently good response to treatment and long-term low disease activity. Conclusion High early disease activity, and treatment resistance in the first few months, predict a more chronic longitudinal course of JDM.

rheumatology